Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05286593 · ClinicalTrials.gov registry record · Phase 4
3D PET Myocardial Blood Flow and Rb82 Infusion Profiles
A Phase 4 study, sponsored by Ochsner Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
NCT05286593: Completed Phase 4 study, sponsored by Ochsner Health System.
NCT05286593 is a Phase 4 study that has completed, run by Ochsner Health System. The registered enrollment target is 98 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05286593, a Phase 4 study, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
Study Summary
The investigators seek to test bolus infusions (50ml/min) vs. slow infusions (20 ml/min) of Rb-82 on metrics of coronary blood flow assessed on a modern 3D PET/CT.
Primary Outcome
resting and stress myocardial blood flow in cc/min/g
Interventions
- DRUG Slow Infusion of Rubidium-82
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2021-12-28 |
| Est. Completion | 2022-09-30 |
| Phase | Phase 4 |
What the finished NCT05286593 record still lists
NCT05286593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Slow Infusion of Rubidium-82 is the first listed.
NCT05286593 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05286593 about?
NCT05286593 is a clinical study titled "3D PET Myocardial Blood Flow and Rb82 Infusion Profiles". The investigators seek to test bolus infusions (50ml/min) vs. slow infusions (20 ml/min) of Rb-82 on metrics of coronary blood flow assessed on a modern 3D PET/CT.
What is the current status of trial NCT05286593?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2021-12-28. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT05286593?
The interventions under investigation include: Slow Infusion of Rubidium-82 (DRUG).
Who is sponsoring clinical trial NCT05286593?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05286593's enrollment target sits among peer trials
98 854th of 2000 higher than 1,140 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI